Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
February 2, 2012
|
February 2, 2012
|
January 27, 2012
|
January 25, 2012
|
|
January 25, 2012
|
January 17, 2012
|
January 6, 2012
|
January 5, 2012
|